15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering AstraZeneca PLC, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 8% this year and 6% next, consensus EPS building from about $1.31 next quarter toward $8.78 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to AstraZeneca PLC.
As of Jul, 1 of 1 firms rate AZN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AZN EPS & revenue forecast
EPS · NEXT QUARTER
$1.31
Range $1.29 – $1.32 · 2 analysts
Next period, 2 analysts expect AstraZeneca PLC to earn $1.31 a share (range $1.29 – $1.32), versus — a year earlier. Full-year consensus is $7.64, growing to $8.78 the year after.
REVENUE · NEXT QUARTER
$16.1B
Range $15.8B – $16.3B · 2 analysts · +6% YoY
Revenue is expected to reach $16.1B (range $15.8B – $16.3B), +6.0% year-over-year. Full-year consensus is $63.2B, rising to $66.8B next year.
Top analysts covering AstraZeneca PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AZN.
#1
Seamus Fernandez
Guggenheim
Buy
$162.00-6.0% to target
Coverage
—
+ Follow
#2
MW
Matthew Weston
UBS
Buy
$17600.00+10112.4% to target
Coverage
—
+ Follow
#3
GP
Graham Parry
Citi
Buy
$175.00+1.5% to target
Coverage
—
+ Follow
#4
JS
Justin Smith
Bernstein
Buy
$18900.00+10866.7% to target
Coverage
—
+ Follow
#5
RS
Rajan Sharma
Goldman Sachs
Buy
$16370.00+9398.7% to target
Coverage
—
+ Follow
AZN stock forecast FAQ
Is AZN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover AZN?+
1 analysts have an active rating on AstraZeneca PLC.
Who is the most accurate analyst covering AZN?+
Among analysts who currently cover AZN, Seamus Fernandez of Guggenheim has the strongest overall Quantellect track record. Their current call is Buy with a $162.00 target.
What is AstraZeneca PLC's projected EPS for next quarter?+
The consensus estimate is $1.31 per share (range $1.29 – $1.32) across 2 analysts. Full-year EPS is projected at $7.64, rising to $8.78 the following year.
How much revenue is AstraZeneca PLC expected to report next quarter?+
Consensus revenue is $16.1B (range $15.8B – $16.3B). Full-year revenue is projected at $63.2B, growing to $66.8B next year.
Have analysts been upgrading or downgrading AZN lately?+
As of Jul, 1 of 1 firms rate AZN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AZN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
